Why is Gennex Lab. falling/rising?

As of 17-Nov, Gennex Laboratories Ltd is experiencing a decline in its stock price, currently at 15.05, which represents a decrease of 0.71 or 4.51%. The stock has underperformed its sector today by 4.79%, and while it is trading higher than its 50-day, 100-day, and 200-day moving averages, it is lower than its 5-day and 20-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume on 14 November falling by 61.21% compared to the 5-day average. Over the past year, the stock has seen a substantial decline of 21.12%, contrasting with a positive return of 9.50% from the benchmark index, Sensex.
Broader Market Context: In the short term, Gennex Laboratories Ltd has underperformed the Sensex, which has gained 1.69% over the past week while Gennex has only decreased by 0.40%. Year-to-date, the stock has declined by 7.89%, significantly lagging behind the Sensex's gain of 8.72%. This underperformance may be attributed to the falling investor participation and the stock's inability to maintain momentum compared to the broader market, indicating a lack of confidence among investors in the company's prospects relative to the overall market performance.